These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 39039104)

  • 1. Targeting hyaluronan metabolism-related molecules associated with resistant tumor-initiating cells potentiates chemotherapy efficacy in lung cancer.
    Díaz MA; Fusco M; Benítez CA; Gayet F; García L; Victoria L; Jaramillo S; Bayo J; Zubieta MR; Rizzo MM; Piccioni F; Malvicini M
    Sci Rep; 2024 Jul; 14(1):16803. PubMed ID: 39039104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4Mu Decreases CD47 Expression on Hepatic Cancer Stem Cells and Primes a Potent Antitumor T Cell Response Induced by Interleukin-12.
    Rodríguez MM; Fiore E; Bayo J; Atorrasagasti C; García M; Onorato A; Domínguez L; Malvicini M; Mazzolini G
    Mol Ther; 2018 Dec; 26(12):2738-2750. PubMed ID: 30301668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid inhibition by 4-methylumbelliferone reduces the expression of cancer stem cells markers during hepatocarcinogenesis.
    Sukowati CHC; Anfuso B; Fiore E; Ie SI; Raseni A; Vascotto F; Avellini C; Mazzolini G; Tiribelli C
    Sci Rep; 2019 Mar; 9(1):4026. PubMed ID: 30858465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells.
    Gomez KE; Wu F; Keysar SB; Morton JJ; Miller B; Chimed TS; Le PN; Nieto C; Chowdhury FN; Tyagi A; Lyons TR; Young CD; Zhou H; Somerset HL; Wang XJ; Jimeno A
    Cancer Res; 2020 Oct; 80(19):4185-4198. PubMed ID: 32816856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.
    Song JM; Im J; Nho RS; Han YH; Upadhyaya P; Kassie F
    Mol Carcinog; 2019 Mar; 58(3):321-333. PubMed ID: 30365189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-methylumbelliferone-mediated polarization of M1 macrophages correlate with decreased hepatocellular carcinoma aggressiveness in mice.
    Rodríguez MM; Onorato A; Cantero MJ; Domínguez L; Bayo J; Fiore E; García M; Atorrasagasti C; Canbay A; Malvicini M; Mazzolini GD
    Sci Rep; 2021 Mar; 11(1):6310. PubMed ID: 33737571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
    Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
    PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coating Solid Lipid Nanoparticles with Hyaluronic Acid Enhances Antitumor Activity against Melanoma Stem-like Cells.
    Shen H; Shi S; Zhang Z; Gong T; Sun X
    Theranostics; 2015; 5(7):755-71. PubMed ID: 25897340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan expressed by the hematopoietic microenvironment is required for bone marrow hematopoiesis.
    Goncharova V; Serobyan N; Iizuka S; Schraufstatter I; de Ridder A; Povaliy T; Wacker V; Itano N; Kimata K; Orlovskaja IA; Yamaguchi Y; Khaldoyanidi S
    J Biol Chem; 2012 Jul; 287(30):25419-33. PubMed ID: 22654110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lusianthridin targeting of lung cancer stem cells via Src-STAT3 suppression.
    Bhummaphan N; Petpiroon N; Prakhongcheep O; Sritularak B; Chanvorachote P
    Phytomedicine; 2019 Sep; 62():152932. PubMed ID: 31100681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells.
    Kobayashi I; Takahashi F; Nurwidya F; Nara T; Hashimoto M; Murakami A; Yagishita S; Tajima K; Hidayat M; Shimada N; Suina K; Yoshioka Y; Sasaki S; Moriyama M; Moriyama H; Takahashi K
    Biochem Biophys Res Commun; 2016 Apr; 473(1):125-132. PubMed ID: 26996130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer.
    Yeh CT; Wu AT; Chang PM; Chen KY; Yang CN; Yang SC; Ho CC; Chen CC; Kuo YL; Lee PY; Liu YW; Yen CC; Hsiao M; Lu PJ; Lai JM; Wang LS; Wu CH; Chiou JF; Yang PC; Huang CY
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1180-8. PubMed ID: 23024022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells.
    Quan YH; Lim JY; Choi BH; Choi Y; Choi YH; Park JH; Kim HK
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):399-410. PubMed ID: 30515553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma.
    Bourguignon LY; Wong G; Shiina M
    J Biol Chem; 2016 May; 291(20):10571-85. PubMed ID: 27002147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity.
    Wang L; Liu X; Ren Y; Zhang J; Chen J; Zhou W; Guo W; Wang X; Chen H; Li M; Yuan X; Zhang X; Yang J; Wu C
    Cell Death Dis; 2017 Apr; 8(4):e2746. PubMed ID: 28406482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells.
    Navas T; Pfister TD; Colantonio S; Aziz A; Dieckman L; Saul RG; Kaczmarczyk J; Borgel S; Alcoser SY; Hollingshead MG; Lee YH; Bottaro DP; Hiltke T; Whiteley G; Takebe N; Kinders RJ; Parchment RE; Tomaszewski JE; Doroshow JH
    PLoS One; 2018; 13(6):e0199361. PubMed ID: 29928062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.